PT Saptausaha Gemilangindah Tbk (SAGE)
Jul 31, 2025 - SAGE was delisted (reason: acquired by SUPN)
8.68
-0.02 (-0.23%)
Inactive · Last trade price
on Jul 30, 2025
Company Description
PT Saptausaha Gemilangindah Tbk develops and sells residential and commercial real estate properties in Indonesia.
The company also owns and rents properties; and provides management and consulting services. PT Saptausaha Gemilangindah Tbk was founded in 1992 and is headquartered in Jakarta Pusat, Indonesia.
PT Saptausaha Gemilangindah Tbk is a subsidiary of PT Benteng Terang Sejahtera.
PT Saptausaha Gemilangindah Tbk
| Country | Indonesia |
| Founded | 1992 |
| IPO Date | Jul 18, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 353 |
| CEO | Edward Halim |
Contact Details
Address: Millennium Industrial Estate Building Jakarta Pusat, Massachusetts 10450 Indonesia | |
| Phone | 62 21 391 6338 |
| Website | saptagroup.com |
Stock Details
| Ticker Symbol | SAGE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | IDR |
| CIK Code | 0001597553 |
| CUSIP Number | 78667J108 |
| ISIN Number | US78667J1088 |
| SIC Code | 6552 |
Key Executives
| Name | Position |
|---|---|
| Barry E. Greene | President, Chief Executive Officer and Director |
| Christopher Benecchi | Chief Operating Officer and Treasurer |
| Gregory Shiferman | Senior Vice President, General Counsel and Secretary |
| Michael Quirk Ph.D. | Chief Scientific Officer and Interim Head of Research & Development |
| Ashley Kaplowitz | Director of Investor Relations |
| Pamela Herbster | Senior Vice President and Chief People and Experience Officer |
| Dr. Helen Colquhoun | Senior Vice President of Drug Safety and Pharmacovigilance |
| Dr. Aaron Koenig M.D. | Medical Director of Early Clinical Development |
| Helen Rubinstein | Investor Relations Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 31, 2025 | 25-NSE | Filing |
| Jul 31, 2025 | SC 14D9/A | Filing |
| Jul 31, 2025 | 8-K | Current Report |
| Jul 31, 2025 | SC TO-T/A | Filing |
| Jul 30, 2025 | SCHEDULE 13D/A | Filing |
| Jul 30, 2025 | 10-Q | Quarterly Report |
| Jul 30, 2025 | 8-K | Current Report |
| Jul 29, 2025 | SCHEDULE 13G/A | Filing |
| Jul 28, 2025 | SC 14D9/A | Filing |
| Jul 28, 2025 | SC TO-T/A | Filing |